Pascal Pujol Selected Research

Pascal Pujol Research Topics

Disease

28	Neoplasms (Cancer) 07/2022 - 02/2002
18	Breast Neoplasms (Breast Cancer) 07/2022 - 02/2002
4	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 01/2016
4	Ovarian Neoplasms (Ovarian Cancer) 10/2012 - 02/2002
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
3	Carcinogenesis 10/2005 - 07/2004
2	Carcinoma (Carcinomatosis) 01/2016 - 08/2004
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2016 - 07/2012
2	Ovarian Epithelial Carcinoma 10/2012 - 07/2004
2	Familial Breast Cancer 10/2005 - 07/2004
1	Disease Progression 01/2022
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Cachexia 01/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Adenoma (Adenomas) 01/2016
1	Genomic Instability 01/2016
1	Pain (Aches) 05/2014
1	Unilateral Breast Neoplasms 03/2012
1	Hyperplasia 06/2011
1	Breast Carcinoma In Situ 06/2011
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2011
1	Wilms Tumor (Wilm's Tumor) 11/2008
1	Growth Disorders 11/2008
1	Melanoma (Melanoma, Malignant) 07/2008
1	Cutaneous Malignant Melanoma 07/2008
1	Endometrial Neoplasms (Endometrial Cancer) 07/2006
1	Breast Ductal Carcinoma 12/2005
1	Cysts 08/2004

Drug/Important Bio-Agent (IBA)

9	Estrogens (Estrogen)FDA Link 04/2015 - 02/2002
5	Estrogen ReceptorsIBA 07/2022 - 02/2002
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2004
4	Tamoxifen FDA LinkGeneric 09/2013 - 11/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2006
3	Progesterone Receptors (Progesterone Receptor)IBA 07/2016 - 11/2002
3	Messenger RNA (mRNA)IBA 01/2016 - 02/2002
3	Aromatase InhibitorsIBA 05/2014 - 06/2011
3	Estrogen Receptor betaIBA 08/2004 - 02/2002
3	Estrogen Receptor alphaIBA 08/2004 - 02/2002
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2021
2	Hormones (Hormone)IBA 12/2019 - 07/2016
2	exemestane (Aromasin)FDA Link 05/2014 - 06/2011
2	Letrozole (Femara)FDA LinkGeneric 03/2012 - 01/2005
2	Oral ContraceptivesIBA 10/2005 - 07/2004
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2022
1	ElementsIBA 01/2020
1	Retroelements (Retrotransposon)IBA 01/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2018
1	Peptides (Polypeptides)IBA 09/2017
1	big gastrinIBA 09/2017
1	CateninsIBA 09/2017
1	Humanized Monoclonal AntibodiesIBA 09/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017
1	Biological ProductsIBA 01/2016
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2016
1	Calcibiotic Root Canal SealerIBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Fulvestrant (Faslodex)FDA Link 10/2012
1	afimoxifene (hydroxytamoxifen)IBA 10/2012
1	Raloxifene Hydrochloride (Evista)FDA Link 06/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2008
1	Cell Cycle ProteinsIBA 07/2008
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 07/2008
1	Aromatase (CYP19)IBA 07/2006
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 07/2006
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 07/2006
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2006
1	EnzymesIBA 07/2006
1	Annexin A5IBA 08/2004
1	Steroid Receptors (Steroid Receptor)IBA 11/2002
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2002
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2002
1	fibulinIBA 02/2002
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 02/2002
1	Extracellular Matrix ProteinsIBA 02/2002

Therapy/Procedure

10	Therapeutics 01/2021 - 11/2002
3	Ovariectomy (Oophorectomy) 03/2012 - 07/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 09/2017
2	Salpingo-oophorectomy 02/2020 - 01/2020
1	Precision Medicine 12/2018
1	Immunotherapy 10/2018
1	Mastectomy (Mammectomy) 06/2011
1	Ligation 07/2008
1	Radiotherapy 01/2005
1	Estrogen Replacement Therapy 07/2004
1	Neoadjuvant Therapy 11/2002